Accelerating Protein Degrader Therapeutics Through Integrated Discovery Solutions

• Targeted protein degradation is transforming drug discovery beyond conventional target inhibition
• Success in the TPD field requires integration of biology, chemistry, DMPK, structural biology, and translational sciences
• End-to-end discovery platform at Sai Life Sciences can significantly accelerate degrader advancement from concept to candidate

Speakers:

Joel Austin

Senior Director, Business Development & Marketing

SAI Life Sciences Ltd